The connection between high cholesterol and risk of stroke is questioned. Is Avandia contributing to bone breakage? And more bad news for the GSK diabetes treatment...two healthcare providers drop …
Pharma News 11_16
As is becoming a more common event, this week's news posting is being composed from an airport hotel room. My NJ ASTD colleagues are networking at the Annual Technology Training Showcase in …
Pharma News 10_19
The Good Stuff: BMS gets approval for new oncology drug (for breast cancer) Ixempra. Merck gets new HIV drug (Isentress) approved in the U.S. And, their Januvia diabetes drug gets new uses …
Pharma News 9_14
Prasugrel, the upcoming rival to $6 billion drug Plavix, gets a write-up. This is a crucial new drug for co-promote partners Daiichi-Sankyo and Eli Lilly. Good Samaritan drug rep loses leg, gains …
Pharma News 8_24
Novartis gets approval for Reclast, a once-per-year osteoporosis treatment. That's a game-changer - very cool advance that should lead to far better patient compliance. A long-ish article on Wyeth's …
Nexium the New Avandia? Enough Already!
In a backside-covering move, the FDA has gone public with the "news" that it has nothing to report - yet - about possible heart risks for users of Nexium/Prilosec. Yes, the FDA caught grief for not …
Continue Reading about Nexium the New Avandia? Enough Already! →